Electrical signals applied during the absolute refractory period: An investigational treatment for advanced heart failure in patients with normal QRS duration

Thomas Lawo, Martin Borggrefe, Christian Butter, Gerhard Hindricks, Herwig Schmidinger, Yuval Mika, Daniel Burkhoff, Carlo Pappone, Hani N. Sabbah

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Cardiac resynchronization therapy has been shown to be an effective treatment for patients with systolic ventricular dysfunction, prolonged (>120 ms) QRS duration, and New York Heart Association (NYHA) functional class III or IV symptoms despite optimal medical therapy. However, studies show that a majority of heart failure patients have QRS duration

Original languageEnglish
Pages (from-to)2229-2239
Number of pages11
JournalJournal of the American College of Cardiology
Volume46
Issue number12
DOIs
Publication statusPublished - Dec 20 2005

Fingerprint

Investigational Therapies
Heart Failure
Ventricular Dysfunction
Cardiac Resynchronization Therapy
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Electrical signals applied during the absolute refractory period : An investigational treatment for advanced heart failure in patients with normal QRS duration. / Lawo, Thomas; Borggrefe, Martin; Butter, Christian; Hindricks, Gerhard; Schmidinger, Herwig; Mika, Yuval; Burkhoff, Daniel; Pappone, Carlo; Sabbah, Hani N.

In: Journal of the American College of Cardiology, Vol. 46, No. 12, 20.12.2005, p. 2229-2239.

Research output: Contribution to journalArticle

Lawo, Thomas ; Borggrefe, Martin ; Butter, Christian ; Hindricks, Gerhard ; Schmidinger, Herwig ; Mika, Yuval ; Burkhoff, Daniel ; Pappone, Carlo ; Sabbah, Hani N. / Electrical signals applied during the absolute refractory period : An investigational treatment for advanced heart failure in patients with normal QRS duration. In: Journal of the American College of Cardiology. 2005 ; Vol. 46, No. 12. pp. 2229-2239.
@article{19667e8dc02e437aa97166540c9ab4b0,
title = "Electrical signals applied during the absolute refractory period: An investigational treatment for advanced heart failure in patients with normal QRS duration",
abstract = "Cardiac resynchronization therapy has been shown to be an effective treatment for patients with systolic ventricular dysfunction, prolonged (>120 ms) QRS duration, and New York Heart Association (NYHA) functional class III or IV symptoms despite optimal medical therapy. However, studies show that a majority of heart failure patients have QRS duration",
author = "Thomas Lawo and Martin Borggrefe and Christian Butter and Gerhard Hindricks and Herwig Schmidinger and Yuval Mika and Daniel Burkhoff and Carlo Pappone and Sabbah, {Hani N.}",
year = "2005",
month = "12",
day = "20",
doi = "10.1016/j.jacc.2005.05.093",
language = "English",
volume = "46",
pages = "2229--2239",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "12",

}

TY - JOUR

T1 - Electrical signals applied during the absolute refractory period

T2 - An investigational treatment for advanced heart failure in patients with normal QRS duration

AU - Lawo, Thomas

AU - Borggrefe, Martin

AU - Butter, Christian

AU - Hindricks, Gerhard

AU - Schmidinger, Herwig

AU - Mika, Yuval

AU - Burkhoff, Daniel

AU - Pappone, Carlo

AU - Sabbah, Hani N.

PY - 2005/12/20

Y1 - 2005/12/20

N2 - Cardiac resynchronization therapy has been shown to be an effective treatment for patients with systolic ventricular dysfunction, prolonged (>120 ms) QRS duration, and New York Heart Association (NYHA) functional class III or IV symptoms despite optimal medical therapy. However, studies show that a majority of heart failure patients have QRS duration

AB - Cardiac resynchronization therapy has been shown to be an effective treatment for patients with systolic ventricular dysfunction, prolonged (>120 ms) QRS duration, and New York Heart Association (NYHA) functional class III or IV symptoms despite optimal medical therapy. However, studies show that a majority of heart failure patients have QRS duration

UR - http://www.scopus.com/inward/record.url?scp=28944450990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28944450990&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2005.05.093

DO - 10.1016/j.jacc.2005.05.093

M3 - Article

C2 - 16360051

AN - SCOPUS:28944450990

VL - 46

SP - 2229

EP - 2239

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 12

ER -